Starbucks Denies Coffee Cancer Risk As Prop 65 Trial Opens

By Daniel Siegal (September 8, 2014, 10:40 PM EDT) -- Starbucks Corp. denied that its coffee poses a cancer risk as a California bench trial opened Monday in a nonprofit's bid to have Starbucks coffee labeled as containing a carcinogen under Proposition 65, telling a judge that studies show the levels of the carcinogen acrylamide in its coffee are harmless.

The bench trial will see Los Angeles Superior Court Judge Elihu M. Berle rule on Starbucks' three affirmative defenses against the Council for Education and Research on Toxics' suit, which contends Starbucks' coffee contains enough acrylamide, a known carcinogen, to cause cancer in consumers. CERT alleges Starbucks violated California's Proposition 65,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!